Discovery of the 'pioneer' that opens the genome

January 23, 2018, University of Montreal
Credit: CC0 Public Domain

Our genome contains all the information necessary to form a complete human being. This information, encoded in the genome's DNA, stretches over one to two metres long but still manages to squeeze into a cell about 100 times smaller than a green pea. To do so, the genome has to be compacted.

Now a team led by Jacques Drouin, a researcher at the Montreal Clinical Research Institute (IRCM) and professor at Université de Montréal's Faculty of Medicine, has identified a key that can open up some parts of the compacted or closed genome. The discovery of this key, a pioneer factor, provides novel insight into mechanisms of genome access. The discovery was recently published in Nature Genetics. Like an archaeologist who unearths a long-buried civilization and reveals a whole new culture, this pioneer factor provides access to parts of the genome that were inaccessible due to its compacted state.

Once upon a time, there were two cells

Our lives began when two - an egg and a sperm - meet. Together, they produce a variety of 'progeny' whose functions and properties differ from their own. The human body actually has many types of cells - about 200. How can this diversity be explained? The answer lies in the .

Imagine DNA as a book, with each gene amounting to a page of information. When new cells are formed, an army of translators known as '' is called into action. Each factor reproduces specific pages of the book at various stages in a person's development. Thanks to these stacks of pages, a cell differentiates, acquiring a distinct identity.

"That's why a cell in your liver and a cell in the tip of your toe share the same ancestor," explained Drouin, who is Director of the IRCM's Molecular Genetics Research Unit.

To do their job, transcription factors must have access to the right gene at the right time. But only the uncompacted part of the genome is accessible to transcription factors. So, various parts of the genome have to be "opened" to produce different cells. But how?

The key called Pax7

This is where Jacques Drouin and his PhD student, Alexandre Mayran, stepped in, examining two types of pituitary cells.

"The two types of cells seemed to use the same transcription factors to develop, right up until the very last stage," Drouin recalled. "In theory, they should be identical, but they have completely different functions and are located in different parts of the pituitary."

Trying to understand why, the IRCM researchers focused on one molecule, Pax7, and were able to demonstrated its crucial role. "Pax7 acts like a key, opening specific parts of the genome," said Drouin. "It's what we call a pioneer factor. Acting as a pioneer, Pax7 gives access to 2,500 new sites that transcription factors can bind to and express genes that were previously out of reach."

Perfectly timed choreography

Despite its important role in embryo development, pioneer action is far from being well-understood. Without pioneer factors, our cells wouldn't be able to diversify to such an extent. As well, pioneer action must occur at the right place and at the right time for a tissue to develop normally. If the mechanism fails, some genes will be expressed by mistake and this inappropriate gene expression causes diseases such as cancer.

Pursuing their research, the IRCM team will now investigate Pax7's mechanism of action more thoroughly. "We'd like to identify the proteins that interact with Pax7 in order to open specific parts of the compacted ; these could be future therapeutic targets," said Drouin.

Indeed, pioneers are key factors for reprogramming cells - to produce insulin-secreting cells that people with diabetes need, for example, or neurons to replace those lost in the brains of Parkinson's disease patients. Understanding factors is therefore a priority to realize the promises of cell and gene therapy. For Drouin and his team, the treasure hunt has just begun.

Explore further: Reprogramming cell identity in the pituitary gland

More information: Pioneer factor Pax7 deploys a stable enhancer repertoire for specification of cell fate, Nature Genetics (2018). nature.com/articles/doi:10.1038/s41588-017-0035-2

Related Stories

Reprogramming cell identity in the pituitary gland

October 16, 2012
A team of researchers at the IRCM, supervised by Dr. Jacques Drouin, reprogrammed the identity of cells in the pituitary gland and identified critical mechanisms of epigenetic cell programming. This important discovery, published ...

The surprising role of gene architecture in cell fate decisions

January 16, 2018
Scientists read the code of life—the genome—as a sequence of letters, but now researchers have also started exploring its three-dimensional organisation. In a paper published in Nature Genetics, an interdisciplinary research ...

An important study for Parkinson's disease: Researchers uncover mechanism regulating dopamine levels in the brain

December 11, 2014
Researchers in Montréal led by Jacques Drouin, D.Sc., uncovered a mechanism regulating dopamine levels in the brain by working on a mouse model of late onset Parkinson's disease. The study, conducted in collaboration with ...

Recommended for you

Critical role of DHA on foetal brain development revealed

August 17, 2018
Duke-NUS researchers have found evidence that a natural form of Docosahexaenoic Acid (DHA) made by the liver called Lyso-Phosphatidyl-Choline (LPC-DHA), is critical for normal foetal and infant brain development, and that ...

New algorithm could improve diagnosis of rare diseases

August 17, 2018
Today, diagnosing rare genetic diseases requires a slow process of educated guesswork. Gill Bejerano, Ph.D., associate professor of developmental biology and of computer science at Stanford, is working to speed it up.

Gene silencing critical for normal breast development

August 17, 2018
Researchers have discovered that normal breast development relies on a genetic 'brake', a protein complex that keeps swathes of genes silenced.

Officials remove special rules for gene therapy experiments

August 16, 2018
U.S. health officials are eliminating special regulations for gene therapy experiments, saying that what was once exotic science is quickly becoming an established form of medical care with no extraordinary risks.

Genetic link discovered between circadian rhythms and mood disorders

August 15, 2018
Circadian rhythms are regular 24-hour variations in behaviour and activity that control many aspects of our lives, from hormone levels to sleeping and eating habits.

Ovarian cancer genetics unravelled

August 14, 2018
Patterns of genetic mutation in ovarian cancer are helping make sense of the disease, and could be used to personalise treatment in future.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

FredJose
1 / 5 (1) Jan 24, 2018
As well, pioneer action must occur at the right place and at the right time for a tissue to develop normally. If the mechanism fails, some genes will be expressed by mistake and this inappropriate gene expression causes diseases such as cancer.

One wonders why, when reading things like this, people still believe that life began as some random event involving spontaneous chemical interactions instead of being designed by a supremely intelligent and powerful designer. Biological life is replete with logic. No logic, no life. And logic only comes from intelligence. Period.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.